Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab Combined With Cyclosporine for Primary Membranous Nephropathy
NCT07861204Phase 3Recruiting
- Sponsor
- Peking University First Hospital
- Start
- Jan 2026
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
A Phase 3 trial of cyclosporine in primary membranous nephropathy (PMN), sponsored by Peking University First Hospital. Started Jan 2026; status: recruiting.
02
Drugs
cyclosporine
03
Conditions
primary membranous nephropathy (PMN)
Beyond the preview
Go deeper on NCT07861204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07861204.